Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices

Veronique E. Miron, Samuel K. Ludwin, Peter J. Darlington, Andrew A. Jarjour, Betty Soliven, Timothy E. Kennedy, Jack P. Antel

Research output: Contribution to journalArticlepeer-review

Abstract

Remyelination, which occurs subsequent to demyelination, contributes to functional recovery and is mediated by oligodendrocyte progenitor cells (OPCs) that have differentiated into myelinating cells. Therapeutics that impact remyelination in the CNS could be critical determinants of long-term functional outcome in multiple sclerosis (MS). Fingolimod is a S1P receptor modulator in MS clinical trials due to systemic anti-inflammatory properties, yet may impact cells within the CNS by crossing the blood-brain barrier. Previous studies using isolated dissociated cultures indicate that neural cells express SIP receptors and respond to receptor engagement. Our objective was to assess the effects of fingolimod on myelin-related processes within a multicellular environment that maintains physiological cell-cell interactions, using organotypic cerebellar slice cultures. Fingolimod treatment had no impact on myelin under basal conditions. Fingolimod treatment subsequent to lysolecithin-induced demyelination enhanced remyelination and process extension by OPCs and mature oligodendrocytes, while increasing microglia numbers and immunoreactivity for the astrocytic marker glial fibrillary acidic protein. The number of phagocytosing microglia was not increased by fingolimod. Using SIT receptor specific agonists and antagonists, we determined that fingolimod-induced effects on remyelination and astrogliosis were mediated primarily through S1P3 and S1P5, whereas enhanced microgliosis was mediated through S1P1 and S1P5. Taken together, these data demonstrate that fingolimod modulates multiple neuroglial cell responses, resulting in enhanced remyelination in organotypic slice cultures that maintain the complex cellular interactions of the mammalian brain. (Am J Pathol 2010, 176:2682-2694,- DOI: 10.2353/ajpath.2010.091234)

Original languageEnglish
Pages (from-to)2682-2694
Number of pages13
JournalAmerican Journal of Pathology
Volume176
Issue number6
DOIs
Publication statusPublished - Jun 2010

Keywords

  • Animals
  • Astrocytes
  • Demyelinating Diseases
  • Oligodendroglia
  • Humans
  • Tissue Culture Techniques
  • Lysophosphatidylcholines
  • Receptors, Lysosphingolipid
  • Cerebellum
  • Mice
  • Myelin Sheath
  • Microglia
  • Immunosuppressive Agents
  • Animals, Newborn
  • Multiple Sclerosis
  • Propylene Glycols
  • Stem Cells
  • Sphingosine

Fingerprint

Dive into the research topics of 'Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices'. Together they form a unique fingerprint.

Cite this